PDB14 COST-EFFECTIVENESS ANALYSIS OF THE ACARBOSE PHARMACOLOGICAL TREATMENT AS A PREVENTIVE MEASURE OF THE DEVELOPMENT OF TYPE 2 DIABETES IN SUBJECTS DIAGNOSED OF IMPAIRED GLUCOSE TOLERANCE (IGT)

Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61738-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61738-X/fulltext
Title : PDB14 COST-EFFECTIVENESS ANALYSIS OF THE ACARBOSE PHARMACOLOGICAL TREATMENT AS A PREVENTIVE MEASURE OF THE DEVELOPMENT OF TYPE 2 DIABETES IN SUBJECTS DIAGNOSED OF IMPAIRED GLUCOSE TOLERANCE (IGT)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61738-X&doi=10.1016/S1098-3015(10)61738-X
First page :
Section Title :
Open access? : No
Section Order : 185
Categories :
Tags :
Regions :
ViH Article Tags :